Breakthrough Clinical Trial Aims to Target Cancer’s Hidden Growth Mechanism
Researchers at the Francis Crick Institute in collaboration with Vividion Therapeutics have unveiled a groundbreaking approach to halting cancer progression by selectively disrupting the interaction...
















